Posted by admin in
TEST on 03 2nd, 2009 |
Comments Off
The FDA issued a Public Health Advisory to notify healthcare professionals of three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva.
Original post:
Raptiva FDA Warning